Edges in Network
Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | RPS6KA4 |
Upstream (Parents) |
---|
(<<) CCND3 → RPS6KA4 |
(<<) CD4 → RPS6KA4 |
(<<) DHX9 → RPS6KA4 |
(<<) FGF5 → RPS6KA4 |
(<<) HLA-A → RPS6KA4 |
(<<) KPNA1 → RPS6KA4 |
(<<) MAP2K1 → RPS6KA4 |
(<<) PIK3R5 → RPS6KA4 |
(<<) PIP5K1C → RPS6KA4 |
(<<) RHOT1 → RPS6KA4 |
(<<) RNF111 → RPS6KA4 |
(<<) SMAD5 → RPS6KA4 |
(<<) SMARCC2 → RPS6KA4 |
(<<) SOCS5 → RPS6KA4 |
(<<) TAF9 → RPS6KA4 |
(<<) TOP2B → RPS6KA4 |
Downstream (Children) |
---|
RPS6KA4 → ALOX15B (>>) |
RPS6KA4 → ASB1 (>>) |
RPS6KA4 → CASP5 (>>) |
RPS6KA4 → EHD1 (>>) |
RPS6KA4 → GAD1 (>>) |
RPS6KA4 → KLK5 (>>) |
RPS6KA4 → MMP9 (>>) |
RPS6KA4 → NFATC1 (>>) |
RPS6KA4 → PLA2G3 (>>) |
RPS6KA4 → PLAUR (>>) |
RPS6KA4 → SAA4 (>>) |
RPS6KA4 → SH3TC1 (>>) |